Skip to main content
Premium Trial:

Request an Annual Quote

Benitec Licenses Technology to Revivicor

NEW YORK, Oct. 11 (GenomeWeb News) - Benitec announced last week that it has non-exclusively licensed its DNA-directed RNA interference technology to Revivicor for use in regenerative medicine.

 

According to Benitec, Revivicor will use the technology to downregulate genes in transgenic pigs, creating tissue and organs that can be used for grafting and transplantation in humans.

 

Under the terms of the deal, Benitec received an upfront fee, and is due annual maintenance fees, a milestone payment upon US regulatory approval, and royalty payments. Additional terms were not disclosed.

 

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.